Release Date: 30/11/22 12:19 Summary: Signing of merger agreement documents Price Sensitive: Yes Download Document 11.73MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%